Reduction of thyroid radioactive iodine exposure by oral administration of cyclic oligosaccharides

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource, 1 online resource.
Language
Englisch

Bibliographic citation
Reduction of thyroid radioactive iodine exposure by oral administration of cyclic oligosaccharides ; volume:13 ; number:1 ; day:28 ; month:4 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (28.4.2023), 1-8, 12.2023

Creator
Nishi, Kodai
Hirota, Masahiro
Higaki, Shogo
Shiraishi, Shinya
Kudo, Takashi
Matsuda, Naoki
Ito, Shigeki
Contributor
SpringerLink (Online service)

DOI
10.1038/s41598-023-34254-0
URN
urn:nbn:de:101:1-2023090412071863371199
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Nishi, Kodai
  • Hirota, Masahiro
  • Higaki, Shogo
  • Shiraishi, Shinya
  • Kudo, Takashi
  • Matsuda, Naoki
  • Ito, Shigeki
  • SpringerLink (Online service)

Other Objects (12)

Thyroid Peroxidase Antibodies in Non-Autoimmune Hyperthyroidism Treated with Radioactive Iodine

Thyroid Peroxidase Antibodies in Non-Autoimmune Hyperthyroidism Treated with Radioactive Iodine

Risk factors and clinical characteristics associated with post-radioactive iodine thyroid storm

Risk factors and clinical characteristics associated with post-radioactive iodine thyroid storm

Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma

Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma

Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer

Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer

Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience

Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience

Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance

Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance

How Radioactive Iodine Treatment Affects the Retina

How Radioactive Iodine Treatment Affects the Retina

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma

Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience

Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience

Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients

Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial

131I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine

131I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine

Related objects